Integrated Approaches: Leveraging In Vitro and Ex Vivo Tools for Oncology Research

Patient-derived xenograft (PDX) models are a valuable instrument in oncology. In this webinar, we will show how cell-based assays performed with low passage, PDX-derived material serve as cost- and time-effective tools to select appropriate models as well as conditions for in vivo efficacy studies.

View this webinar to learn how an integrated approach based on PDX in vitro, in vivo, and bioinformatics data will facilitate drug development and enhance the speed of preclinical oncology research.

Presenter

  • Armin Maier, PhD, Head of In Vitro Services & Compound Management, Charles River